What is Cardiac Biotech Solutions Inc. (CBSC) stock price today?

Cardiac Biotech Solutions Inc. (CBSC) is currently trading at $0.03, up 0% today.

What is CBSC P/E ratio?

Cardiac Biotech Solutions Inc.'s P/E ratio is -5.56. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is CBSC return on equity (ROE)?

Cardiac Biotech Solutions Inc.'s return on equity (ROE) is 42.18%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Cardiac Biotech Solutions Inc.'s market cap?

Cardiac Biotech Solutions Inc. has a market capitalization of $4.96M.

OTC · Medical - Instruments & Supplies

Cardiac Biotech Solutions Inc. (CBSC) Stock

$0.03 +0.00% OTC: CBSC Healthcare

Operating globally through its international subsidiaries, Cardiac Biotech Solutions Inc. delivers advanced products and services for non-invasive, mobile cardiac monitoring.

Valuation

Metric	Value
Price	$0.03
Market Cap	$4.96M
P/E Ratio	-5.56
P/B Ratio	-2.16
P/S Ratio	32.50
EPS (TTM)	$-0.01
52-Week High	$0.06
52-Week Low	$0.02
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	42.18%
ROA	-183.77%
ROCE	66.91%
Gross Margin	29.51%
Operating Margin	-757.45%
Net Margin	-594.50%
Debt/Equity	-0.23
Current Ratio	0.22

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-2.0M	$-2.0M	$-2.0M	$-1.0M	$-1.0M
Net Profit	$-6.0M	$-2.0M	$-2.0M	$-2.0M	$-1.0M
EPS	$-0.07	$-0.02	$-0.01	$-0.01	$-0.01
Op Margin	-2475.4%	-2550.7%	-1181.5%	-3207.4%	-757.5%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$1.0M	$0	$0	$0	$0
Total Liabilities	$0	$1.0M	$1.0M	$2.0M	$3.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$0	$0	$0	$0	$1.0M

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-1.0M	$-1.0M	$-1.0M	—	$-1.0M
Investing Cash Flow	$0	$0	$0	—	$0
Financing Cash Flow	$0	$0	$0	—	$0
Net Cash Flow	$0	$0	$0	—	$0
Free Cash Flow	$-1.0M	$-1.0M	$-1.0M	$0	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.07
EV / EBITDA	-4.75
FCF Yield	-12.83%
Quick Ratio	0.15
Interest Coverage	-4.57
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CPIVFCaptiva Verde Wellness Corp.	$0.02	-8.54%	-6.86	$4.58M	0.00%
ENZNViskase Companies, Inc.	$4.71	+1.29%	-0.91	$31.14M	0.00%
FZMDFuse Medical, Inc.	$0.02	-31.27%	10.00	$1.48M	0.00%
IDXGInterpace Biosciences, Inc.	$1.50	-8.13%	0.29	$41.48M	0.00%
LIFDLFTD Partners Inc.	$0.20	-2.50%	-0.10	$2.89M	0.00%

About Cardiac Biotech Solutions Inc.

Operating globally through its international subsidiaries, Cardiac Biotech Solutions Inc. delivers advanced products and services for non-invasive, mobile cardiac monitoring. The company's portfolio includes FDA and CE-approved EKG devices, sophisticated cloud-based data acquisition software, and intuitive smartphone applications compatible with both iOS and Android platforms. These solutions are designed to boost patient engagement for individuals prone to irregular heart rhythms, simultaneously providing medical professionals with highly accurate diagnostic insights. Furthermore, its wholly owned U.S. subsidiary, My-Cardia (USA), Inc., focuses on creating wearable ECG recording devices that patients can utilize in an ambulatory setting for periods extending up to 30 days.

Cardiac Biotech Solutions Inc. is headquartered in US.

Cardiac Biotech Solutions Inc. (CBSC) stock trades at $0.03 with a market capitalization of $4.96M. The stock is valued at a price-to-earnings (P/E) ratio of -5.56, price-to-book of -2.16, price-to-sales of 32.50. Over the past 52 weeks the stock has ranged between $0.02 and $0.06, and currently trades 50.0% below its 52-week high.

On profitability, Cardiac Biotech Solutions Inc. generates a return on equity (ROE) of 42.18% — well above the market average, a sign of a high-quality business, return on capital employed of 66.91%, an operating margin of -757.45%, a net profit margin of -594.50%.

Official website: cardiacbiotech.com